Overdose of Mucovital in details
Symptoms of Mucovital overdose include rash, flushing, nausea, vomiting, bronchospasm, edema, tachycardia, hypotension, respiratory depression, hemolysis, disseminated intravascular coagulation and renal failure.
In cases of overdosage, discontinue Mucovital. Institute appropriate symptomatic and supportive therapy (eg, postural drainage and bronchoaspiration).
Mucovital warnings
Mucovital should be used with caution in patients with a history of peptic ulcer disease because of a theoretical risk that mucolytics may disrupt the gastric mucosal barrier.
Mucovital precautions
After proper administration of Mucovital, an increased volume of liquefied bronchial secretions may occur. If the patient cannot expectorate efficiently, postural drainage and bronchoaspiration must be used to avoid retention of secretions.
Carefully observe asthmatics under treatment with Mucovital. If bronchospasm occurs, discontinue Mucovital immediately.
The presence of a sulfur-like odor does not indicate an alteration of the product, but is a characteristic of the drug substance contained in the preparation.
Use with caution in patients with a history of peptic ulcer disease. Drug-induced nausea and vomiting may increase the risk of gastrointestinal hemorrhage in patients predisposed to the condition and because of the theoretical risk that mucolytics may disrupt the gastric mucosal barrier.
Phenylketonurics: Mucovital contains phenylalanine as one of the metabolites of aspartame.
Use in Pregnancy: The safe use of Mucovital during pregnancy has not been established. Mucovital should be used in pregnancy only if the potential benefit justifies the potential risk to the fetus.
Use in Lactation: It is not known whether Mucovital is excreted in human milk. Therefore, do not administer to breastfeeding women unless, in the opinion of a physician, the potential benefits of Mucovital justify the possible risk.
References
- DrugBank. "carbocysteine". http://www.drugbank.ca/drugs/DB04339 (accessed September 17, 2018).
- MeSH. "Expectorants". https://www.ncbi.nlm.nih.gov/mesh/68... (accessed September 17, 2018).
Reviews
Consumer reviews
There are no reviews yet. Be the first to write one! |
Information checked by Dr. Sachin Kumar, MD Pharmacology